Suven jumps on new product patents in USA - The New Indian Express

Suven jumps on new product patents in USA

Published: 26th March 2014 12:19 PM

Last Updated: 26th March 2014 12:19 PM

Suven Life Sciences shares jumped on Wednesday after the company gets two product patents from USA (8598204 & 8551718) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029 and 2030 respectively.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Parkinson and Schizophrenia.

Shares of the company are trading at Rs 72.45, up Rs 1.25, or 1.76% at the Bombay Stock Exchange (BSE) on Wednesday at 11:01 a.m.The scrip has touched an intra-day high of Rs 73.20 and low of Rs 70. The total volume of shares traded at the BSE is 251,368.In the earlier session, the shares climbed 0.64%, or Rs 0.45, at Rs 71.20.Currently, the stock is trading down 13.13% from its 52-week high of Rs 83.40 and above 229.32% over the 52-week low of Rs 22.

comments powered by Disqus

Disclaimer: We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the NIE editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.


Read More



follow us Mobile Site iPad News Hunt Android RSS Tumblr Linekin Pinterest Youtube Google Plus Twitter Facebook